Vaccine Forum and more
To view this email as a web page, click here
[Global Bio Conference 2019] updates. Try subscribing to Biomedicine industry newsletter updated every week! [Click]
New Vaccine Development Trends and National Regulatory Authorities' Perspectives
#1. Next generation vaccine development leveraging RNA technology
mRNA(messenger RNA) based vaccine development is increasingly growing. mRNA is a medium for transcription of the gene in the nucleus to be translated into protein. Targeting mRNA is more effective than other drugs targeting proteins and less risky that modifying the gene in the nucleus (genome integration risk). The mRNA based treatments cover a wide span of diseases from Cancer-immunotherapies to respiratory cell virus vaccines including rabies or Ebola virus. The CureVac AG presentation by Lidia Oostvogels will offer an introduction on responsiveness profile result and LNP( lipid nanoparticle) agents!
#2.Quality assessment considerations when reviewing new vaccines for approval
PEI(Paul-Ehrlich-Institut) is a senior federal authority in the field of pharmaceutical products providing services in public health under the German Public Health Service. It engages in biopharmaceutical products review for approval, national lot release, pharmacovigilance and runs own experimental research in the field of life science. It is also involved in international cooperation with international organizations including WHO. PEI vaccine expert Dr. Ralf Wagner states that the advent of new vaccines is improving the quality assessment measures and perspectives for assessment for approval. Please come and check the most updated trend of the regulatory authority on how the meaningful potency assay for batch release correlated to the functional activation is set and what are the restriction requirements against cell substrates and more!
Global Safety Management System and Recent Regulatory Developments of Human Tissues
Speaker Spotlight :
Recent Regulations Trends on Human Tissues (Czech) and Doner Eligibility Procedures for Human Tissues
Karkoska Jan, NTIC (Czech Republic)
GB-Communication? 1:1 Meeting! The Global Bio Conference 2019 is the largest event for domestic biopharmaceutical industry with over 3,700 biopharma leaders from all over the world (36 countries). Already, 966 global bio experts have completed their registration processes for GBC 2019. Don't you believe that among the attendees there will surely be someone who will answer my concerns, someone who will understand the value of my technology or even someone who could become my global partner? Do not miss opportunities within GBC!
#GB-Communication
#How to Participate in GB-Communication
Pre-registration for GBC 2019 continues until June 19 (Wed.)
We will be back with a further variety of GBC forum news! Please add gbc@kobia.kr to your mailing list! '-'/
Copyright @ GBC 2019. All right reserved.
info@kobia.kr ์์ธ์ ์์ด๊ตฌ ๋จ๋ถ์ํ๋ก 333๊ธธ 10 ์์ผ๋น๋ฉ 4์ธต 02-725-8250 ์์ ๊ฑฐ๋ถ Unsubscribe |